REMS Assessment Is As Challenging As Initial Design, Regulators Acknowledge
This article was originally published in The Pink Sheet Daily
Unintended adverse consequences and impact on health care delivery must be part of the assessment, OSE Director Gerald Dal Pan says.
You may also be interested in...
Results from early Risk Evaluation and Mitigation Strategy assessments suggest sponsors have a ways to go before they can show the vast majority of patients receive, read and understand Medication Guides.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.